Preliminary results of a randomized controlled trial carried out with a fixed combination of S-adenosyl-L-methionine and betaine versus amitriptyline in patients with mild depression

International Journal of General Medicine

Volumn 8, Issue , 2015, Pages 73-78

  Di Pierro, Francesco ^a   Settembre, Roberto ^b  

^a Velleja Research   (Italy)

^b DI VENERE HOSPITAL   (Italy)

Author keywords

Amitriptyline; Betaine; Methyl donor; Moderate depression; SAMe

Indexed keywords

ALANINE AMINOTRANSFERASE; AMITRIPTYLINE; ASPARTATE AMINOTRANSFERASE; BETAINE; BETAINE PLUS S ADENOSYLMETHIONINE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; BLOOD ANALYSIS; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRELIMINARY COMMUNICATION; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SEXUAL DYSFUNCTION; STOMACH PAIN; TREATMENT DURATION; TREATMENT RESPONSE; VERY ELDERLY; VITAL SIGN; ZUNG SELF RATING DEPRESSION SCALE;

EID: 84922441964     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S79518     Document Type: Article

References (17)

1. Peeters F, Huibers M, Roelofs J, et al. The clinical effectiveness of evidence-based interventions for depression: a pragmatic trial in routine practice. J Affect Disord. 2013;145(3):349-355.
2. Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry. 2008;63(7):699-704.
3. Bentley SM, Pagalilauan GL, Simpson SA. Major depression. Med Clin North Am. 2014;98(5):981-1005.
4. Howland RH. Dietary supplement drug therapies for depression. J Psychosoc Nurs Ment Health Serv. 2012;50(6):13-16.
5. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008;13(3): 216-226.
6. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr. 2002; 76(5):1158S-1161S.
7. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002;76(5):1172S-1176S.
8. Gören JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BM. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy. 2004;24(11):1501-1507.
9. Bottiglieri T. Folate, vitamin B12, and S-adenosylmethionine. Psychiatr Clin North Am. 2013;36(1):1-13.
10. Obeid R. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients. 2013;5(9):3481-3495.
11. Knopman D, Patterson M. An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients. Alzheimer Dis Assoc Disord. 2001;15(3):162-165.
12. Di Pierro F, Orsi R, Settembre R. Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild to moderate depression. J Multidiscip Healthc. 2015;8:39-45.
13. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med. 2002;48(3):206-208.
14. Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol. 2006;62(1):123-146.
15. Beckmann N, Sharma D, Gulbins E, Becker KA, Edelmann B. Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogs. Front Physiol. 2014;5:331.
16. Rudroju N, Bansal D, Talakokkula ST, et al. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. Pain Physician. 2013;16(6): E705-E714.
17. Shippy RA, Mendez D, Jones K, Cergnul I, Karpiak SE. S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS. BMC Psychiatry. 2004;4:38.